Photo taken from Cancer Research Institute/X
Mar 1, 2024, 03:00
A survey of U.S. oncologists on the use of innovative treatments – Cancer Research Institute
Cancer Research Institute shared a post on LinkedIn:
“Advancements in the research and treatment of advanced non-small cell lung cancer (NSCLC) has led to the introduction of new treatment options over the past decade but the high prevalence of disease and mortality rate warrants further research to help tailor treatment approaches to each individual patient.
We conducted a recent survey of U.S. oncologists with Regeneron, which asked them how often they use these innovative treatments and what work needs to be done to continue to improve patient care.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 15:20
Nov 19, 2024, 15:17
Nov 19, 2024, 15:14
Nov 19, 2024, 15:12
Nov 19, 2024, 14:54
Nov 19, 2024, 14:42
Nov 19, 2024, 14:20